Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis

被引:38
作者
Boiarsky, Rebecca [1 ,2 ,3 ]
Haradhvala, Nicholas J. [1 ,4 ]
Alberge, Jean-Baptiste [1 ,5 ,6 ]
Sklavenitis-Pistofidis, Romanos [1 ,5 ,6 ]
Mouhieddine, Tarek H. [7 ]
Zavidij, Oksana [8 ]
Shih, Ming-Chieh [2 ,3 ]
Firer, Danielle [1 ]
Miller, Mendy [1 ]
El-Khoury, Habib [5 ]
Anand, Shankara K. [1 ]
Aguet, Francois [1 ]
Sontag, David [1 ,2 ,3 ]
Ghobrial, Irene M. [1 ,5 ,6 ]
Getz, Gad [1 ,6 ,9 ,10 ]
机构
[1] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
[2] MIT, CSAIL, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[3] MIT, IMES, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[4] Harvard Grad Program Biophys, Cambridge, MA USA
[5] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[6] Harvard Med Sch, Boston, MA 02115 USA
[7] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Div Hematol & Med Oncol, New York, NY 10029 USA
[8] Constellat Pharmaceut, Cambridge, MA USA
[9] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA
[10] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
关键词
LOW CD27 EXPRESSION; MULTIPLE-MYELOMA; MOLECULAR CLASSIFICATION; MONOCLONAL GAMMOPATHY; PLASMA-CELLS; RISK; ABNORMALITIES; PROGRESSION; DIAGNOSIS; INSIGHTS;
D O I
10.1038/s41467-022-33944-z
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Multiple myeloma is a plasma cell malignancy almost always preceded by precursor conditions, but low tumor burden of these early stages has hindered the study of their molecular programs through bulk sequencing technologies. Here, we generate and analyze single cell RNA-sequencing of plasma cells from 26 patients at varying disease stages and 9 healthy donors. In silico dissection and comparison of normal and transformed plasma cells from the same bone marrow biopsy enables discovery of patient-specific transcriptional changes. Using Non-Negative Matrix Factorization, we discover 15 gene expression signatures which represent transcriptional modules relevant to myeloma biology, and identify a signature that is uniformly lost in abnormal cells across disease stages. Finally, we demonstrate that tumors contain heterogeneous subpopulations expressing distinct transcriptional patterns. Our findings characterize transcriptomic alterations present at the earliest stages of myeloma, providing insight into the molecular underpinnings of disease initiation. Development of multiple myeloma is preceded by precursor conditions. Here, the authors use single cell RNA-sequencing of plasma cells from patients across disease stages to identify genomic signatures present even at the earliest stages of disease.
引用
收藏
页数:15
相关论文
共 64 条
[1]   Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 [J].
Barbie, David A. ;
Tamayo, Pablo ;
Boehm, Jesse S. ;
Kim, So Young ;
Moody, Susan E. ;
Dunn, Ian F. ;
Schinzel, Anna C. ;
Sandy, Peter ;
Meylan, Etienne ;
Scholl, Claudia ;
Froehling, Stefan ;
Chan, Edmond M. ;
Sos, Martin L. ;
Michel, Kathrin ;
Mermel, Craig ;
Silver, Serena J. ;
Weir, Barbara A. ;
Reiling, Jan H. ;
Sheng, Qing ;
Gupta, Piyush B. ;
Wadlow, Raymond C. ;
Le, Hanh ;
Hoersch, Sebastian ;
Wittner, Ben S. ;
Ramaswamy, Sridhar ;
Livingston, David M. ;
Sabatini, David M. ;
Meyerson, Matthew ;
Thomas, Roman K. ;
Lander, Eric S. ;
Mesirov, Jill P. ;
Root, David E. ;
Gilliland, D. Gary ;
Jacks, Tyler ;
Hahn, William C. .
NATURE, 2009, 462 (7269) :108-U122
[2]   Genomic patterns of progression in smoldering multiple myeloma [J].
Bolli, Niccolo ;
Maura, Francesco ;
Minvielle, Stephane ;
Gloznik, Dominik ;
Szalat, Raphael ;
Fullam, Anthony ;
Martincorena, Inigo ;
Dawson, Kevin J. ;
Samur, Mehmet Kemal ;
Zamora, Jorge ;
Tarpey, Patrick ;
Davies, Helen ;
Fulciniti, Mariateresa ;
Shammas, Masood A. ;
Tai, Yu Tzu ;
Magrangeas, Florence ;
Moreau, Philippe ;
Corradini, Paolo ;
Anderson, Kenneth ;
Alexandrov, Ludmil ;
Wedge, David C. ;
Avet-Loiseau, Herve ;
Campbell, Peter ;
Munshi, Nikhil .
NATURE COMMUNICATIONS, 2018, 9
[3]   Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients [J].
Broyl, Annemiek ;
Hose, Dirk ;
Lokhorst, Henk ;
de Knegt, Yvonne ;
Peeters, Justine ;
Jauch, Anna ;
Bertsch, Uta ;
Buijs, Arjan ;
Stevens-Kroef, Marian ;
Beverloo, H. Berna ;
Vellenga, Edo ;
Zweegman, Sonja ;
Kersten, Marie-Josee ;
van der Holt, Bronno ;
el Jarari, Laila ;
Mulligan, George ;
Goldschmidt, Hartmut ;
van Duin, Mark ;
Sonneveld, Pieter .
BLOOD, 2010, 116 (14) :2543-2553
[4]   Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression [J].
Bustoros, Mark ;
Sklavenitis-Pistofidis, Romanos ;
Park, Jihye ;
Redd, Robert ;
Zhitomirsky, Benny ;
Dunford, Andrew J. ;
Salem, Karma ;
Tai, Yu-Tzu ;
Anand, Shankara ;
Mouhieddine, Tarek H. ;
Chavda, Selina J. ;
Boehner, Cody ;
Elagina, Liudmila ;
Neuse, Carl Jannes ;
Cha, Justin ;
Rahmat, Mahshid ;
Taylor-Weiner, Amaro ;
Van Allen, Eliezer ;
Kumar, Shaji ;
Kastritis, Efstathis ;
Leshchiner, Ignaty ;
Morgan, Elizabeth A. ;
Laubach, Jacob ;
Casneuf, Tineke ;
Richardson, Paul ;
Munshi, Nikhil C. ;
Anderson, Kenneth C. ;
Trippa, Lorenzo ;
Aguet, Francois ;
Stewart, Chip ;
Dimopoulos, Meletios-Athanasios ;
Yong, Kwee ;
Bergsagel, P. Leif ;
Manier, Salomon ;
Getz, Gad ;
Ghobrial, Irene M. .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (21) :2380-+
[5]   Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma [J].
Chng, W-J ;
Huang, G. F. ;
Chung, T. H. ;
Ng, S. B. ;
Gonzalez-Paz, N. ;
Troska-Price, T. ;
Mulligan, G. ;
Chesi, M. ;
Bergsagel, P. L. ;
Fonseca, R. .
LEUKEMIA, 2011, 25 (06) :1026-1035
[6]   Role of Tumor-Derived Chemokines in Osteolytic Bone Metastasis [J].
Coniglio, Salvatore J. .
FRONTIERS IN ENDOCRINOLOGY, 2018, 9
[7]   Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis [J].
Davies, FE ;
Dring, AM ;
Li, C ;
Rawstron, AC ;
Shammas, MA ;
O'Connor, SM ;
Fenton, JAL ;
Hideshima, T ;
Chauhan, D ;
Tai, IT ;
Robinson, E ;
Auclair, D ;
Rees, K ;
Gonzalez, D ;
Ashcroft, AJ ;
Dasgupta, R ;
Mitsiades, C ;
Mitsiades, N ;
Chen, LB ;
Wong, WH ;
Munshi, NC ;
Morgan, GJ ;
Anderson, KC .
BLOOD, 2003, 102 (13) :4504-4511
[8]   STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia [J].
Debant, Marjolaine ;
Burgos, Miguel ;
Hemon, Patrice ;
Buscaglia, Paul ;
Fali, Tinhinane ;
Melayah, Sarra ;
Le Goux, Nelig ;
Vandier, Christophe ;
Potier-Cartereau, Marie ;
Pers, Jacques-Olivier ;
Tempescul, Adrian ;
Berthou, Christian ;
Bagacean, Cristina ;
Mignen, Olivier ;
Renaudineau, Yves .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[9]   Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine [J].
Dutta, Ankit K. ;
Alberge, Jean-Baptiste ;
Sklavenitis-Pistofidis, Romanos ;
Lightbody, Elizabeth D. ;
Getz, Gad ;
Ghobrial, Irene M. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (04) :223-236
[10]   Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability [J].
Dutta, Ankit K. ;
Fink, J. Lynn ;
Grady, John P. ;
Morgan, Gareth J. ;
Mullighan, Charles G. ;
To, Luen B. ;
Hewett, Duncan R. ;
Zannettino, Andrew C. W. .
LEUKEMIA, 2019, 33 (02) :457-468